Key takeaways from the Patient Centricity and Engagement conference, exploring how trust, inclusion and meaningful ...

Women in Healthcare Leadership podcast series. Now on its fourth series, “Hear from Her” has established itself globally as ...

Pompe disease is a rare, progressive neuromuscular disease, with infantile onset being the most aggressive form ...

In the emerging framework, a medicine’s value will increasingly depend on how effectively care is delivered around it’ ...

The Communiqué Awards returned for its 28th year on 2 July to celebrate excellence in healthcare communications and showcase the work shaping the industry. Once again held at the Grosvenor House Hotel ...

Patients who had received only one prior line of systemic therapy showed a stronger trend for overall survival and ...

For pharma, its AI progress appears to be slowed by a methodical procession of AI adoption through a series of chicanes.

Zymeworks, a biotechnology company managing a portfolio of licensed healthcare assets and developing a diverse pipeline of ...

Oxford BioTherapeutics (OBT) has announced two clinical milestones from its long-running oncology collaboration with ...

Candel Therapeutics has appointed Mark Sims as Chief Commercial Officer, effective 6 July 2026. Sims is a seasoned oncology ...

A single word—manageable—can minimise the real burden of treatment side effects, and it’s time clinical trial communication ...

Sanofi has appointed Paulo Fontoura as Executive Vice President, Global Head of Research & Development Pharma, effective 1 ...